---
title: "Fuchun Technology director Lin Mei plans to reduce holdings by no more than 51,500 shares"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/228032876.md"
description: "According to the Zhitong Finance APP, Fuchun Technology announced that the company's director and senior executive Lin Mei plans to reduce his holdings in the company by no more than 51,500 shares, which is no more than 0.01% of the company's total share capital"
datetime: "2025-02-12T12:20:05.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/228032876.md)
  - [en](https://longbridge.com/en/news/228032876.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/228032876.md)
generator: "portal-rs"
---

# Fuchun Technology director Lin Mei plans to reduce holdings by no more than 51,500 shares

According to the Zhitong Finance APP, Fuchun Technology (300299.SZ) announced that the company's director and senior executive Lin Mei plans to reduce his holdings in the company by no more than 51,500 shares, which is no more than 0.01% of the company's total share capital

### Related Stocks

- [300299.CN](https://longbridge.com/en/quote/300299.CN.md)

## Related News & Research

- [Ships adopt makeshift anti-drone defences as Black Sea attacks intensify](https://longbridge.com/en/news/297784645.md)
- [08:04 ETKearney releases the Circular Fashion Index 2026](https://longbridge.com/en/news/297782637.md)
- [12:17 ETDSC® Unveils MORPH Adaptable Materials Platform and Advanced Foam Construction](https://longbridge.com/en/news/297811010.md)
- [08:46 ETAsendia USA Helps Retailers Navigate New EU Customs Rules with Free e-Book and Webinar](https://longbridge.com/en/news/297788892.md)
- [Xinhua Pharma unit Xincat’s azithromycin tablets pass China generic consistency evaluation](https://longbridge.com/en/news/297485179.md)

---
> **Disclaimer: This article is for reference only and does not constitute any investment advice.**